FI105032B - Menetelmä 5-substituoitujen pyrrolo[2,3-d]pyrimidiinien valmistamiseksi - Google Patents

Menetelmä 5-substituoitujen pyrrolo[2,3-d]pyrimidiinien valmistamiseksi Download PDF

Info

Publication number
FI105032B
FI105032B FI934182A FI934182A FI105032B FI 105032 B FI105032 B FI 105032B FI 934182 A FI934182 A FI 934182A FI 934182 A FI934182 A FI 934182A FI 105032 B FI105032 B FI 105032B
Authority
FI
Finland
Prior art keywords
formula
mmol
preparation
pyrrolo
mixture
Prior art date
Application number
FI934182A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934182A (fi
FI934182A0 (fi
Inventor
Charles Jackson Barnett
Thomas Michael Wilson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/066,831 external-priority patent/US5416211A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI934182A0 publication Critical patent/FI934182A0/fi
Publication of FI934182A publication Critical patent/FI934182A/fi
Application granted granted Critical
Publication of FI105032B publication Critical patent/FI105032B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI934182A 1992-09-25 1993-09-24 Menetelmä 5-substituoitujen pyrrolo[2,3-d]pyrimidiinien valmistamiseksi FI105032B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95151592A 1992-09-25 1992-09-25
US95151592 1992-09-25
US08/066,831 US5416211A (en) 1992-09-25 1993-05-24 Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US6683193 1993-05-24

Publications (3)

Publication Number Publication Date
FI934182A0 FI934182A0 (fi) 1993-09-24
FI934182A FI934182A (fi) 1994-03-26
FI105032B true FI105032B (fi) 2000-05-31

Family

ID=26747196

Family Applications (2)

Application Number Title Priority Date Filing Date
FI934182A FI105032B (fi) 1992-09-25 1993-09-24 Menetelmä 5-substituoitujen pyrrolo[2,3-d]pyrimidiinien valmistamiseksi
FI981709A FI981709A (fi) 1992-09-25 1998-08-06 Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI981709A FI981709A (fi) 1992-09-25 1998-08-06 Menetelmä 5-substituoitujen 2-amino-4-okso-pyrrolo/2,3-d/-pyrimidiinien valmistamiseksi

Country Status (17)

Country Link
US (4) US5663339A (no)
EP (1) EP0589720A3 (no)
JP (1) JPH06211862A (no)
CN (1) CN1038415C (no)
AU (1) AU667568B2 (no)
BR (1) BR9303876A (no)
CA (1) CA2106630A1 (no)
CZ (1) CZ283281B6 (no)
FI (2) FI105032B (no)
HU (1) HUT70208A (no)
IL (1) IL107041A (no)
MX (1) MX9305833A (no)
MY (1) MY111886A (no)
NO (1) NO180587C (no)
NZ (1) NZ248725A (no)
PL (1) PL173738B1 (no)
RU (1) RU2127274C1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923287A4 (en) * 1996-08-30 2001-08-01 Lilly Co Eli NON-CLASSIC PYRROLO (2,3-D) PYRIMIDINE ANTIFOLATE
US7863444B2 (en) 1997-03-19 2011-01-04 Abbott Laboratories 4-aminopyrrolopyrimidines as kinase inhibitors
CN1213998C (zh) * 1997-09-26 2005-08-10 伊莱利利公司 用于制造抗叶酸剂的方法和中间体
US6262262B1 (en) * 1997-09-26 2001-07-17 Eli Lilly And Company Processes and intermediates useful to make antifolates
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
US7071199B1 (en) 1999-09-17 2006-07-04 Abbott Gmbh & Cco. Kg Kinase inhibitors as therapeutic agents
PT1373225E (pt) * 2001-04-04 2006-10-31 Bionumerik Pharmaceuticals Inc Processo para acoplamento de aminoacidos a um esqueleto de antifolato
CN100344615C (zh) * 2004-11-25 2007-10-24 重庆医药工业研究院有限责任公司 制备N-(吡咯并[2,3-d]嘧啶-5-基)酰基谷氨酸衍生物的方法及中间体
EP1934226A2 (en) * 2006-08-14 2008-06-25 Sicor, Inc. Highly pure pemetrexed diacid and processes for the preparation thereof
US8232376B2 (en) 2007-06-29 2012-07-31 Ricoh Company, Ltd. Azo compound and method of preparing the azo compound
CN101417998B (zh) 2007-10-24 2012-10-24 重庆医药工业研究院有限责任公司 一种培美曲塞盐的纯化方法
WO2012056285A1 (en) * 2010-10-25 2012-05-03 Fresenius Kabi Oncology Ltd. An improved process for the preparation of pemetrexed
CN103030640B (zh) * 2012-06-11 2015-04-22 江苏豪森医药集团连云港宏创医药有限公司 一种培美曲塞或其盐的制备方法
ITRM20120398A1 (it) * 2012-08-08 2014-02-09 Berlin Chemie Ag Procedimento di sintesi pemetrexed e suo sale di lisina.
EP2997031A1 (en) 2013-05-17 2016-03-23 Instytut Farmaceutyczny Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid
NZ630292A (en) 2013-11-25 2015-02-27 Shilpa Medicare Ltd Process for crystalline pemetrexed dipotassium salt
CN109721604B (zh) * 2019-01-25 2021-03-23 南京亚东启天药业有限公司 培美曲塞酸的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
JP2983254B2 (ja) * 1989-06-14 1999-11-29 武田薬品工業株式会社 ピロロ〔2,3―d〕ピリミジン誘導体の製造法およびその中間体
KR0162654B1 (ko) * 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
EP0530537B1 (en) * 1991-08-12 1997-01-08 Takeda Chemical Industries, Ltd. Condensed pyrimidine derivatives, their production and use as antitumor agents
JP3144903B2 (ja) * 1991-08-21 2001-03-12 エーザイ株式会社 縮合ピリミジン誘導体
US5235053A (en) * 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US5278307A (en) * 1992-09-25 1994-01-11 Eli Lilly And Company Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates
US5426187A (en) * 1993-11-30 1995-06-20 Eli Lilly And Company Process for the preparation of 4-hydroxy-5-substituted ethynylpyrrolo [2,3-d]pyrimidine intermediates

Also Published As

Publication number Publication date
PL173738B1 (pl) 1998-04-30
CZ283281B6 (cs) 1998-02-18
NO180587B (no) 1997-02-03
NO180587C (no) 1997-05-14
CA2106630A1 (en) 1994-03-26
US5644058A (en) 1997-07-01
BR9303876A (pt) 1994-03-29
IL107041A (en) 2000-02-17
CN1038415C (zh) 1998-05-20
IL107041A0 (en) 1993-12-28
NZ248725A (en) 1995-06-27
FI934182A (fi) 1994-03-26
HU9302654D0 (en) 1993-12-28
EP0589720A3 (en) 1994-06-22
EP0589720A2 (en) 1994-03-30
NO933395L (no) 1994-03-28
US5663339A (en) 1997-09-02
RU2127274C1 (ru) 1999-03-10
HUT70208A (en) 1995-09-28
CZ195293A3 (en) 1994-04-13
AU667568B2 (en) 1996-03-28
MY111886A (en) 2001-02-28
MX9305833A (es) 1994-06-30
JPH06211862A (ja) 1994-08-02
NO933395D0 (no) 1993-09-23
FI934182A0 (fi) 1993-09-24
FI981709A0 (fi) 1998-08-06
CN1087910A (zh) 1994-06-15
AU4757593A (en) 1994-03-31
US5892034A (en) 1999-04-06
US5612482A (en) 1997-03-18
FI981709A (fi) 1998-08-06

Similar Documents

Publication Publication Date Title
US5416211A (en) Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
FI105032B (fi) Menetelmä 5-substituoitujen pyrrolo[2,3-d]pyrimidiinien valmistamiseksi
Rosowsky et al. 2, 4-Diaminothieno [2, 3-d] pyrimidine analogs of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase
EA037663B1 (ru) СОЕДИНЕНИЯ ДЛЯ УЛУЧШЕНИЯ СПЛАЙСИНГА мРНК
IL98482A (en) 1 6-Dihydro-5-) 2, 5-Phenyl converted twice (- H7- Pyrazolo -] D-, 3 4 [Pyrimidio- 7-Ones and pharmaceutical preparations containing them
JPH10503762A (ja) 抗増殖剤およびgarft阻害剤として有用な化合物
Darwish et al. Synthesis and antimicrobial evaluation of some new pyrazole, fused pyrazolo [1, 5-a]-pyrimidine and pyrazolo [1, 5-d] pyrimido [4, 5-d][1, 2, 3] triazine derivatives
roaiah et al. Design, efficient synthesis, mechanism of reaction and antiproliferative activity against cancer and normal cell lines of a novel class of fused pyrimidine derivatives
Said et al. Synthesis and biological evaluation of new thiazolopyrimidines
Rosowsky et al. 2, 4-Diaminopyrido [3, 2-d] pyrimidine inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii
Holtwick et al. Guanine, hypoxanthine, and xanthine analog. Synthesis of imidazo [1, 5-a]-1, 3, 5-triazinones via rearrangement
Khalil et al. New pyrimidine derivatives: synthesis and application of thiazolo [3, 2-a]-triazolo [4, 3-a]-pyrimidine as bactericides, fungicides and bioregulators
EP0576211B1 (en) Process for the synthesis of 4-hydroxy-5-halopyrrolo 2,3-D pyrimidine intermediates
US5236926A (en) 9-substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors or PNP for pharmaceutical compositions
US4288365A (en) Pyrido derivatives
AU2004314335A1 (en) Two-phase method for the synthesis of selected pyrazolopyrimidines
Elneairy et al. Reactions with dimethylformamide‐dimethylacetal: Synthesis and reactions of several new pyridine and pyrazolo [3, 4‐b] pyridine derivatives
Ahmed A Convenient Synthesis for Some New Pyrido [4′, 3′: 4, 5] thieno [2, 3-d] pyrimidines and Related Fused 1, 2, 4-Triazolo and 1, 3, 4-Thiadiazolo-derivatives
Dalloul Synthesis of nitrogen-containing dispiroheterocyles (I) using nitrilimines
Gangjee et al. Conformationally restricted tricyclic analogues of lipophilic pyrido [2, 3‐d] pyrimidine antifolates
Coburn et al. Mesoionic purinone analogs. VIII. Synthesis and properties of mesoionic 5‐substituted‐6‐methylimidazo [1, 2‐c] pyrimidine‐2, 7‐diones
CZ283345B6 (cs) Způsob přípravy v poloze 5 substituovaného derivátu pyrrolo [2,3-d]pyrimidinu
Gaafar et al. Novel one-pot synthesis of thiazolo [3, 2-a] pyrimidin-5-one as a key compound for poly nuclear heterocycles
Yamada et al. A new selective preparation of ethyl 7‐aminopteridine‐6‐carboxylate derivatives and related compound
FI88036B (fi) Foerfarande foer framstaellning av saosom bensodiazepinreceptoragonister/antagonister anvaendbara 2-aryl-tetrahydro(pyrido- och pyrrolo)/e//1,2,4/triazolo/1,5-c/pyrimidoner